Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Journal of Medical Genetics|October 27, 2017
Contribution of de novo and mosaic TP53 mutations to Li-Fraumeni syndromeMariette Renaux-Petel, Françoise Charbonnier, Jean-Christophe Théry, et al.Pediatric Blood & Cancer|January 6, 2025
Pulmonary Consequences of Surgical Treatment in Children's Primary Lung Tumors: A National Retrospective StudyFlavie Godard, Aurore Haffreingue, Frédéric Hameury, et al.International Journal of Cancer|October 17, 2022
Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in FranceVictoria Corvest, Perrine Marec-Bérard, Cyril Lervat, et al.British Journal of Cancer|November 17, 2025
Interest of a sequential multimodal approach for the treatment of newly diagnosed patients with multimetastatic Ewing sarcoma: results of the French prospective CombinaiR3 phase II trialValérie Laurence, Nina Jehanno, Sylvain Dureau, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2024
Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving ALK-Targeted TherapyCharles Bobin, Yasmine Iddir, Charlotte Butterworth, et al.British Journal of Haematology|November 14, 2018
Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort studySébastien Héritier, Mohamed-Aziz Barkaoui, Jean Miron, et al.Neuro-Oncology Advances|July 4, 2024
Medulloblastomas with ELP1 pathogenic variants: A weakly penetrant syndrome with a restricted spectrum in a limited age windowLéa Guerrini-Rousseau, Julien Masliah-Planchon, Mathilde Filser, et al.American Journal of Hematology|April 28, 2023
Molecular and clinicopathologic characterization of pediatric histiocytosesZofia Hélias-Rodzewicz, Jean Donadieu, Nathalie Terrones, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line TherapySébastien Héritier, Jean-François Emile, Mohamed-Aziz Barkaoui, et al.Neuro-Oncology|December 28, 2024
Nanopore Sequencing as a Cutting-Edge Technology for Medulloblastoma ClassificationMathilde Filser, Jacob Torrejon, Kevin Merchadou, et al.Pageof 5